RecruitingNot ApplicableNCT05262907

Ventripoint Single Ventricle Study

Assessment of Ventricular Volumes and Function in Single Ventricle Patients Using Ventripoint 3D Echocardiography


Sponsor

Duke University

Enrollment

100 participants

Start Date

Jul 8, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.


Eligibility

Inclusion Criteria1

  • All patients with functional single ventricles will be included, regardless of age or surgical palliation stage, who have had or are having a clinically ordered transthoracic echocardiogram and/or cardiac MRI.

Exclusion Criteria1

  • Patients with congenital heart disease other than functional single ventricles, patients with single ventricle physiology (but not single ventricle anatomy) following a biventricular conversion pathway, or patients unable to understand or consent in English will be excluded.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETransthoracic Echocardiogram or Cardiac MRI

Non-invasive imaging of the heart to evaluate structure and function.

DEVICEVentripoint Echocardiogram

Non-invasive ultrasound of the heart to evaluate structure and function through 3D imaging.


Locations(1)

Duke University

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05262907


Related Trials